Objective: Observational studies suggest that infections are a common complication of therapeutic hypothermia. We performed a systematic review and meta-analysis of randomized trials to examine the risk of infections in patients treated with hypothermia. Data Sources: PubMed, Embase, and the Cochrane Central Register of Controlled Trials were systematically searched for eligible studies up to October 1, 2012. Study Selection: We included randomized controlled clinical trials of therapeutic hypothermia induced in adults for any indication, which reported the prevalence of infection in each treatment group. Data Extraction: For each study, we collected information about the baseline characteristics of patients, cooling strategy, and infections. Data Synthesis: Twenty-three studies were identified, which included 2,820 patients, of whom 1,398 (49.6%) were randomized to hypothermia. Data from another 31 randomized trials, involving 4,004 patients, could not be included because the occurrence of infection was not reported with sufficient detail or not at all. The risk of bias in the included studies was high because information on the method of randomization and definitions of infections lacked in most cases, and assessment of infections was not blinded. In patients treated with hypothermia, the prevalence of all infections was not increased (rate ratio, 1.21 [95% CI, 0.95-1.54]), but there was an increased risk of pneumonia and sepsis (risk ratios, 1.44 [95% CI, 1.10-1.90]; 1.80 [95% CI, 1.04-3.10], respectively). Conclusion: The available evidence, subject to its limitations, strongly suggests an association between therapeutic hypothermia and the risk of pneumonia and sepsis, whereas no increase in the overall risk of infection was observed. All future randomized trials of hypothermia should report on this important complication. (Crit Care Med 2014; 42:231-242) 
T herapeutic hypothermia, the intentional reduction of body temperature, is increasingly used as a treatment for acute brain injury. In randomized trials, hypothermia reduced mortality and improved neurological outcomes in adults with hypoxic-ischemic brain damage after cardiac arrest (1) , in newborns with hypoxic ischemic encephalopathy (2), but not in patients with traumatic brain injury (3, 4) or during surgery for intracranial aneurysms (5) . Furthermore, hypothermia is a promising treatment for ischemic stroke (6, 7) . One large phase III trial of cooling for ischemic stroke is in progress (unique identifier: NCT01123161) and another will start shortly (unique identifier: NCT01833312).
Infections are frequent complications in patients hospitalized for cardiac arrest, traumatic brain injury, or stroke and have been associated with poor outcomes (8) (9) (10) . Recent observational studies suggest that cooling increases the risk of infection after cardiac arrest (11) . In contrast, randomized trials have reported no evidence that therapeutic hypothermia in adults is associated with an increased infection rate (1, 2, (12) (13) (14) . However, these trials, and meta-analyses of trials limited to a single indication for hypothermia, may be too small to detect a relation between hypothermia and infection. This is important because if infections do occur more often in patients treated with hypothermia and if this is associated with a poorer outcome, then the therapeutic benefits of hypothermia might be increased through the use of prophylactic antibiotics.
We therefore performed a systematic review and meta-analysis of all randomized trials of therapeutic hypothermia, irrespective of indication, to assess whether cooling is associated with an increased risk of infections.
MATERIAL AND METHODS

Literature Search
Randomized controlled trials of therapeutic hypothermia were identified from PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) up to October 1, 2012 , with the search terms ("cooling" or "hypothermia" and "randomised" or "randomized" or "randomly"). We searched reference lists of the identified relevant studies for additional citations and compared the results of our search with those of published Cochrane reviews.
Eligibility Criteria
We included all randomized and pseudorandomized clinical trials of therapeutic hypothermia versus control in adult patients. Studies with hypothermia as part of a procedure (e.g., clipping of an intracranial aneurysm) were included, as were studies in which the control group was actively managed to normothermia. We excluded studies with no full text available; in languages other than English, Dutch, or German; using temperature modulation with antipyretics as the active treatment; involving local cooling without lowering of total body temperature; and which did not report the number of infections or the number of patients with an infection. Infections could be reported as "infection" in general or more specifically as pneumonia, urinary tract infection, sepsis, or any other specific infection.
Outcome Definition
The primary outcome measure of this meta-analysis is "any infection." Pancreatitis was not considered an infection, because the etiology of pancreatitis is not necessarily infectious. The occurrence of fever alone, without other evidence of an infection, was not considered an infection. Secondary outcomes of this meta-analysis are the occurrence of pneumonia, urinary tract infection, or sepsis.
Study Selection and Data Extraction
Two reviewers (M.G., P.H.C.K.) independently applied the eligibility criteria to all titles and abstracts, and if necessary fulltext articles, extracted the data using a standardized form, and resolved discrepancies by discussion. For each study, we collected information about the baseline characteristics of patients (type of injury), cooling strategy (whether hypothermia was used as procedural treatment, mode and duration of hypothermia, target temperature, whether the patient was mechanically ventilated, and time until start of treatment), and infections (prevalence, definition as reported in the original article).
Assessment of Risk of Bias
The risk of bias was estimated independently by two reviewers (M.G., P.H.C.K.) using the Cochrane Risk of Bias Methods (15) . Publication bias was assessed by constructing a funnel plot based on the primary outcome and with Egger's regression test (16) .
Data Analysis
We used RevMan 5.1 (Copenhagen: The Nordic Cochrane Collaboration, 2011) for data analysis. We calculated rate ratios (the ratio of the prevalence rate of infections in the hypothermia groups to that in the control groups) and 95% CIs for the primary outcome, unadjusted for baseline variables, with a random effects model. We calculated rate ratios rather than risk ratios because most articles just reported the total number of infections and did not mention whether some patients had more than a single infection ( events. For the secondary outcomes (pneumonia, urinary tract infection, or sepsis), we considered it most likely that the majority of patients had only a single infectious event. We therefore calculated risk ratios (the ratio of the risk of infections in the hypothermia groups to that in the control groups) and 95% CIs for the secondary outcomes with a random effects model. We assessed statistical heterogeneity with the I-squared (I 2 ) index both in overall analyses and in subgroup analyses (17) .
Subgroup Analysis
We analyzed the risk of infections in subgroups of studies, based on the type of injury, duration of cooling, whether hypothermia was applied as part of a procedure, the mode of hypothermia, and the use of mechanical ventilation. These subgroup analyses were prespecified in the protocol. A prespecified subgroup analysis based on the target temperature could not be performed because most studies used a range of target temperatures instead of a single one. We therefore performed a post hoc analysis based on the temperature achieved. Because some studies have suggested that even active management to normothermia increases the risk of infection, a post hoc subgroup analysis exploring the impact of prophylactic normothermia in the control group was undertaken after the results had been compiled. Subgroup differences were analyzed with the I 2 index.
RESULTS
We identified 4,351 unique articles of which 144 were read in full. One additional article was identified from a published Cochrane meta-analysis. Twenty-three articles were included in this meta-analysis (Fig. 1) . Thirty-one articles on randomized controlled trials of hypothermia, involving 4,004 patients, were excluded because they did not report the rate of infections with sufficient detail (n = 8) or not at all (n = 23). There were no significant differences in the effects of hypothermia on mortality or functional outcomes between studies included and excluded from our meta-analysis. The 23 included studies involved 2,820 patients, of whom 1,398 (49.6%) had been randomized to hypothermia. Of these 23 studies, eight used hypothermia during a procedure only. Of the other 15 studies, 10 involved patients with traumatic brain injury, four with ischemic stroke, and one with cardiac arrest. Surface cooling was used in 17 studies, endovascular cooling in five, and one article did not specify the mode of cooling. The duration of cooling ranged from several hours for procedural hypothermia to several days for traumatic brain injury. One nonprocedural hypothermia study did not specify the duration of cooling. In 18 studies, patients were intubated and mechanically ventilated. All articles reported at least one type of infection. Sixteen articles reported on the occurrence of pneumonia, six on urinary tract infection, and six on sepsis. One article reported only on all infectious complications together, not specified per type of infection. A definition of infections was given in four articles ( Table 2) . None of the articles mentioned that the occurrence of infections was assessed blinded to treatment allocation, and the exact mode of randomization was reported in 11 articles.
An evaluation of the risk of bias is presented in Table 3 . Given the lack of uniform and explicit definitions of infections, the open assessment of infections, and the lack of information The terms "low, " "unclear, " and "high" refer to the risk of bias according to the Cochrane Risk of Bias Methods (15) .
on the methods of randomization in the large majority of studies, there was a high risk of bias. The funnel plot did not show major asymmetry, suggesting no major effect of bias on the results (Fig. 2) . In addition, no statistically significant effect of publication bias was found with Egger's regression (p = 0.47). A total of 579 infectious events were reported, of which 316 occurred in patients treated with hypothermia and 263 in controls (rate ratio, 1.21 [95% CI, 0.95-1.54]). The degree of heterogeneity (I 2 ) was 33% in the overall analysis (Fig. 3) , suggesting moderate heterogeneity between studies in the prevalence of infection, perhaps reflecting the different clinical settings (17 (Fig. 4) .
In meta-analyses limited to studies of ischemic stroke or traumatic brain injury, no differences were found in the risk of infections between both groups (Fig. 5) . In the only study of cardiac arrest providing sufficient data, the risk of infections was not significantly higher in patients treated with hypothermia than in controls (Fig. 5) . A trend toward a higher overall infection rate was observed only in patients cooled for more than 12 hours (Fig. 6) . Where hypothermia was induced as part of a procedure and only for the duration of that procedure, there was no increased prevalence of infection (rate ratio, 1.02 [95% CI, 0.69-1.50] in patients Figure 2 . Funnel plot of study precision against the log rate ratio of infections. In the absence of publication bias, the pattern of points should resemble an inverted funnel. The achieved temperature did not significantly affect the rate ratio of infections, but nine studies had to be excluded from this analysis as the achieved temperature was not reported (Supplemental Fig. 5 , Supplemental Digital Content 1, http://links.lww.com/CCM/A724, which describes the effect of hypothermia on the occurrence of infections by context: achieved temperature [rate ratio]).
Excluding the three studies using prophylactic normothermia in the control group did not change the overall results (rate ratio, 1.08 [95% CI, 0.86-1.35]; forest plot not shown).
DISCUSSION
In this systematic review and meta-analysis, we found an increased risk of both pneumonia and sepsis in patients treated with hypothermia, although the prevalence of sepsis was low. No convincing evidence of an increased risk of all infections in patients treated with hypothermia compared with controls was found. Cooling limited to the duration of an invasive procedure, for example, the clipping of an intracranial aneurysm, did not increase the rate ratio of all infections. An increased risk of infection in patients treated with hypothermia might be expected because hypothermia decreases the secretion of proinflammatory cytokines and also inhibits leukocyte migration and phagocytosis. Suppression of neuroinflammation is one of the presumed neuroprotective mechanisms of therapeutic hypothermia, but this may come at the cost of an increased risk of infection (18) . This is supported by the observation that unintentional hypothermia during surgery has convincingly been associated with an increased risk of wound infections (19) .
In a previous meta-analysis (20) of therapeutic hypothermia in traumatic brain injury, a two-fold increased risk of pneumonia in patients treated with hypothermia was reported. However, in a later Cochrane review on the same topic, this finding was not confirmed (4) . One reason for this discrepancy may be underreporting of infections in randomized trials, but differences between studies in patient selection and in the definition of infections may also play a role. A recent meta-analysis on complications of hypothermia after cardiac arrest showed a trend toward an increased pneumonia rate, which was just not statistically significant, possibly because of the relatively small number of trials (8) and patients (795) included (12) .
It has been suggested that a longer duration of cooling increases the risk of infection (18) . In our meta-analysis, we indeed found a trend toward a higher risk of infections when cooling was maintained for more than 12 hours than for shorter periods. However, cooling durations of more than 24 hours all involved patients with traumatic brain injury, and cooling durations of 12 hours involved procedural cooling in all but one of the studies. We therefore cannot rule out that the association between the risk of infection and the duration of cooling is caused by confounding factors.
The present systematic review and meta-analysis is the first to specifically evaluate the risk of infection in a large number of patients treated with hypothermia for different indications. Because the review was limited to randomized and pseudorandomized trials, the risk of bias was reduced.
Our review draws attention to important limitations of published reports of randomized trials of hypothermia and therefore may support the design and reporting of future studies. Subject to these limitations, the available evidence summarized in this review strongly suggests an association between therapeutic hypothermia and the risk of pneumonia and sepsis, whereas no increase in the overall risk of infection was observed.
Certain limitations of our study have to be considered. First, there was a moderate heterogeneity in effect size across the studies. We included studies of various types of injury and thus various patient populations. Furthermore, there was a large variation in the mode, duration, and depth of cooling. This should be considered when interpreting the results of the overall analysis. Therefore, we analyzed subgroups in which there was more homogeneity and analyzed our data with a random effects model rather than with a fixed effects model. Second, we included three studies in our meta-analysis in which the patients in the control group received prophylactic normothermia. These patients were actively managed to a body temperature of less than 37.5°C (21) (22) (23) . Some studies suggest that even with active normothermia, the risk of infections is increased (24, 25) . Excluding these studies from our meta-analysis did however not change the results.
Third, we did not assess the effects of therapeutic hypothermia on mortality and neurological outcomes. These have already been reported in earlier systematic reviews and metaanalyses (1, 2, 4-6), and repeating these analyses would not have added to the existing literature on hypothermia.
Our results are limited by the quality and availability of the existing literature. We had to exclude 31 articles involving 4,004 patients. Eight of these 31 articles (26-33) described "no significant differences in infection rate between both groups," but because no numbers were reported, we could not add these to the meta-analysis. The other 23 articles just did not report on the occurrence of infections. According to the CONSORT statement, all adverse events occurring in a trial should be reported (34) . We consider the occurrence of an infection as important, also because this has been related to increased mortality and poorer neurological outcomes (8-10). Although we can only speculate on the reasons for not reporting numbers of infections in a very substantial part of the trials, we think that the main reason is poor reporting. Theoretically, infections could not have been reported because they simply did not occur, but this appears highly unlikely in the relevant patient populations.
The definition of infection was not clear in most articles. In many cases, this is likely to have been a clinical diagnosis, based on clinical symptoms such as fever and elevated infection variables in the blood. However, it has been suggested that infection variables such as C-reactive protein and leukocytes have a limited predictive value in hypothermic patients (25) . In the presence of infection, these variables can be normal or only slightly elevated in cooled patients. However, because of the short duration of hypothermia, any infection left untreated will have been detected shortly after termination of active cooling. We therefore think that there is no reason to assume underreporting of infections in patients treated with hypothermia.
The open assessment of infections may have resulted in detection bias, but even in ongoing and future trials of hypothermia, this limitation is almost unavoidable.
In the majority of articles, it was not clear whether infections occurred more than once in a single patient. For this reason, we used the rate ratio for the primary outcome of all infections combined. Because we considered it most likely that in the large majority of patients with a specific infection such as pneumonia this did not recur, we used the more common risk ratio for the analyses of the secondary outcomes.
The follow-up period varied considerably between studies, but given the fact that infections related to hypothermia are likely to occur during or early after the termination of cooling, we do not think this will have had an important effect on the results of our study.
A separate analysis based on target temperature was not possible, because most studies used a range of target temperatures instead of a single one. The analysis based on the achieved temperature was limited by the fact that the achieved temperature was not reported in all studies.
Future randomized trials of hypothermia should prospectively assess and report the occurrence of infections, also based on established definitions. Further research should focus on identifying high-risk patients and on the effect of prophylactic treatment with antibiotics.
CONCLUSIONS
Cooling increased the risk of pneumonia and sepsis, but no convincing evidence of an increased overall rate of infections was observed. Clinicians treating patients with hypothermia should be aware of this common side effect so that treatment can start early.
